Arch Chemicals’ Transformation

As Michael Campbell nears the end of his 13-year tenure as Arch Chemicals’ chairman and CEO, his goals are to complete a portfolio cleanup begun more than 10 years ago, and to achieve major margin improvement. Campbell has been at the helm of Arch since it was spun off from Olin in 1999, and has focused the company on biocides, which now account for about 90% of sales. Arch is actively pursuing divestments for its $165-million performance urethanes and its $20-million hydrazine businesses. Campbell will step down in April 2012. A successor has not been named.

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers